Biomarkers of acute kidney injury: a concise review of current literature

1 Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012 Aug 24; 380(9843):756-66. DOI: 10.1016/S0140-6736(11)61454-2 Search in Google Scholar

2 Simsek A, Tugcu V, Tasci AI. New biomarkers for the quick detection of acute kidney injury. ISRN Nephrol. 2012 Nov 1;2013:394582. DOI: 10.5402/2013/394582 Search in Google Scholar

3 Ostermann M, Karsten E, Lumlertgul N. Biomarker-Based Management of AKI: Fact or Fantasy? 2022;146(3):295-01. DOI: 10.1159/000518365 Search in Google Scholar

4 Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury-pathophysiological basis and clinical performance. Acta Physiol (Oxf). 2017 Mar;219(3):554-72. DOI: 10.1111/apha.12764 Search in Google Scholar

5 Albert C, Haase M, Albert A, Zapf A, Braun-Dullaeus RC, Haase-Fielitz A. Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?. Ann Lab Med. 2021 Jan;41(1):1-15. DOI: 10.3343/alm.2021.41.1.1 Search in Google Scholar

6 Zhang WR, Parikh CR. Biomarkers of Acute and Chronic Kidney Disease. Annu Rev Physiol. 2019 Feb 10;81:309-33. DOI: 10.1146/annurev-physiol-020518-114605 Search in Google Scholar

7 Edelstein CL. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis. 2008 Jul;15(3):222-34. DOI: 10.1053/j.ackd.2008.04.003 Search in Google Scholar

8 Teo SH, Endre ZH. Biomarkers in acute kidney injury (AKI). Best Pract Res Clin Anaesthesiol. 2017 Sep;31(3):331-44. DOI: 10.1016/j.bpa.2017.10.003 Search in Google Scholar

9 Wen Y, Parikh CR. Current concepts and advances in biomarkers of acute kidney injury. Crit Rev Clin Lab Sci. 2021 Aug;58(5):354-68. DOI: 10.1080/10408363.2021.1879000 Search in Google Scholar

10 Cravedi P, Remuzzi G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol. 2013 Oct;76(4):516-23. DOI: 10.1111/bcp.12104 Search in Google Scholar

11 George Bakris. Proteinuria A Link to Understanding Changes in Vascular Compliance? Hypertension. 2005 Sep1; 46 (3):473-74. DOI: 10.1161/01.HYP.0000178188.29446.48 Search in Google Scholar

12 Pugh D, Gallacher PJ, Dhaun N. Management of Hypertension in Chronic Kidney Disease. Drugs. 2019 Mar;79(4):365-79. DOI: 10.1007/s40265-019-1064-1 Search in Google Scholar

13 Jiang W, Chen Z, Xu J, Luo Z, Teng J, Ding X, et al. Proteinuria is a risk factor for acute kidney injury after cardiac surgery in patients with stages 3-4 chronic kidney disease: a case control study. BMC Cardiovasc Disord. 2023 Feb 10;23(1):77. DOI: 10.1186/s12872-023-03102-4 Search in Google Scholar

14 Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008;48:463-93. DOI: 10.1146/annurev.pharmtox.48.113006.094615 Search in Google Scholar

15 Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H. Sepsis-Associated Acute Kidney Injury. Crit Care Clin. 2021 Apr;37(2):279-01. DOI: 10.1016/j.ccc.2020.11.010 Search in Google Scholar

16 Brodie AC, Johnston TJ, Lloyd P, Hemsworth L, Barabas M, Keoghane SR. Reducing the rate of negative ureteroscopy: predictive factors and the role of preoperative imaging. Ann R Coll Surg Engl. 2022 Sep;104(8):588-93. DOI: 10.1308/rcsann.2021.0260 Search in Google Scholar

17 Zou C, Wang C, Lu L. Advances in the study of subclinical AKI biomarkers. Front Physiol. 2022 Aug 24;13:960059. DOI: 10.3389/fphys.2022.960059 Search in Google Scholar

18 Rehberg PB. Studies on Kidney Function: The Rate of Filtration and Reabsorption in the Human Kidney. Biochem J. 1926;20(3):447-60. DOI: 10.1042/bj0200447 Search in Google Scholar

19 Grubb AO. Cystatin C--properties and use as diagnostic marker. Adv Clin Chem. 2000;35:63-99. DOI: 10.1016/S0065-2423(01)35015-1 Search in Google Scholar

20 Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985 Nov;28(5):830-38. DOI: 10.1038/ki.1985.205 Search in Google Scholar

21 Murty MS, Sharma UK, Pandey VB, Kankare SB. Serum cystatin C as a marker of renal function in detection of early acute kidney injury. Indian J Nephrol. 2013 May;23(3):180-83. DOI: 10.4103/0971-4065.111840 Search in Google Scholar

22 Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med. 1999 Apr;37(4):389-95. DOI: 10.1515/CCLM.1999.064 Search in Google Scholar

23 Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004 Sep;66(3):1115-22. DOI: 10.1111/j.1523-1755.2004.00861.x Search in Google Scholar

24 Nejat M, Pickering JW, Walker RJ, Endre ZH. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant. 2010 Oct;25(10):3283-89. DOI: 10.1093/ndt/gfq176 Search in Google Scholar

25 Nakhjavan-Shahraki B, Yousefifard M, Ataei N, Baikpour M, Ataei F, Bazargani B, et al. Accuracy of cystatin C in prediction of acute kidney injury in children; serum or urine levels: which one works better? A systematic review and meta-analysis. BMC Nephrol. 2017 Apr 3;18(1):120. DOI: 10.1186/s12882-017-0539-0 Search in Google Scholar

26 Bell M, Granath F, Mårtensson J, Löfberg E, Ekbom A, Martling CR (Karolinska Intensive care Nephrology Group). Cystatin C is correlated with mortality in patients with and without acute kidney injury. Nephrol Dial Transplant. 2009 Oct;24(10):3096-102. DOI: 10.1093/ndt/gfp196 Search in Google Scholar

27 Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008 Oct;74(8):1059-069. DOI: 10.1038/ki.2008.341 Search in Google Scholar

28 Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, et al. Cystatin C and contrast-induced acute kidney injury. Circulation. 2010 May 18;121(19):2117-122. DOI: 10.1161/CIRCULATIONAHA.109.919639 Search in Google Scholar

29 Soto K, Coelho S, Rodrigues B, Martins H, Frade F, Lopes S, et al. Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol. 2010 Oct;5(10):1745-54. DOI: 10.2215/CJN.00690110 Search in Google Scholar

30 Haines RW, Fowler AJ, Liang K, Pearse RM, Larsson AO, Puthucheary Z, et al. Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness. Clin J Am Soc Nephrol. 2023 Aug 1;18(8):997-005. DOI: 10.2215/CJN.0000000000000203 Search in Google Scholar

31 Wyler von Ballmoos M, Likosky DS, Rezaee M, Lobdell K, Alam S, Parker D, et al. Elevated preoperative Galectin-3 is associated with acute kidney injury after cardiac surgery. BMC Nephrol. 2018 Oct 20;19(1):280. DOI: 10.1186/s12882-018-1093-0 Search in Google Scholar

32 Doi K, Negishi K, Ishizu T, Katagiri D, Fujita T, Matsubara T, et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med. 2011 Nov;39(11):2464-69. DOI: 10.1097/CCM.0b013e318225761a Search in Google Scholar

33 Burrello J, Monticone S, Burrello A, Bolis S, Cristalli CP, Comai G, et al. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant. Nephrol Dial Transplant. 2023 Feb 28;38(3):764-77. DOI: 10.1093/ndt/gfac259 Search in Google Scholar

34 Guo Y, Li L, Hu S. Circulating Galectin-3 levels and Diabetic Nephropathy: a systematic review and meta-analysis. BMC Nephrol. 2023 Jun 8;24(1):163. DOI: 10.1186/s12882-023-03226-x Search in Google Scholar

35 Kikuchi Y, Kobayashi S, Hemmi N, Ikee R, Hyodo N, Saigusa T, et al. Galectin-3-positive cell infiltration in human diabetic nephropathy. Nephrol Dial Transplant. 2004 Mar;19(3):602-07. DOI: 10.1093/ndt/gfg603 Search in Google Scholar

36 Hara A, Niwa M, Noguchi K, Kanayama T, Niwa A, Matsuo M, et al. Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases. Biomolecules. 2020 Mar 3;10(3):389. DOI: 10.3390/biom10030389 Search in Google Scholar

37 Al-Salam S, Jagadeesh GS, Sudhadevi M, Yasin J. Galectin-3 and Autophagy in Renal Acute Tubular Necrosis. Int J Mol Sci. 2024 Mar 22;25(7):3604. DOI: 10.3390/ijms25073604 Search in Google Scholar

38 Horiuchi Y, Wettersten N, Van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, et al. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure. J Card Fail. 2023 Mar;29(3):269-77. DOI: 10.1016/j.cardfail.2022.09.017 Search in Google Scholar

39 Sun H, Peng J, Cai S, Nie Q, Li T, Kellum JA, et al. A translational study of Galectin-3 as an early biomarker and potential therapeutic target for ischemic-reperfusion induced acute kidney injury. J Crit Care. 2021 Oct;65:192-99. DOI: 10.1016/j.jcrc.2021.06.013 Search in Google Scholar

40 Younes-Ibrahim M, Younes-Ibrahim M. Biomarkers and kidney diseases: a brief narrative review. J Lab Prec Med. 2022 Jul 30; 7:20. DOI: 10.21037/jlpm-22-1 Search in Google Scholar

41 Yu B, Jin L, Yao X, Zhang Y, Zhang G, Wang F, et al. TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy. Theranostics. 2023 Jul 31;13(13):4356-75. DOI: 10.7150/thno.84655 Search in Google Scholar

42 Volarevic V, Markovic BS, Jankovic MG, Djokovic B, Jovicic N, Harrell CR, et al. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs. Theranostics. 2019 Aug 14;9(20):5976-001. DOI: 10.7150/thno.33959 Search in Google Scholar

43 Zhao Y, Feng X, Li B, Sha J, Wang C, Yang T, et al. Dexmedetomidine Protects Against Lipopolysaccharide-Induced Acute Kidney Injury by Enhancing Autophagy Through Inhibition of the PI3K/AKT/mTOR Pathway. Front Pharmacol. 2020 Feb25; 25(11):128. DOI: 10.3389/fphar.2020.00128 Search in Google Scholar

44 Li HY, Yang S, Li JC, Feng JX. Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity. Biosci Rep. 2018 Dec 18;38(6):BSR20181803. DOI: 10.1042/BSR20181803 Search in Google Scholar

45 Tanase DM, Gosav EM, Radu S, Costea CF, Ciocoiu M, Carauleanu A, et al. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity. Int J Mol Sci. 2019 Oct 2022;20(20):5238. DOI: 10.3390/ijms20205238 Search in Google Scholar

46 Vogel MJ, Mustroph J, Staudner ST, Leininger SB, Hubauer U, Wallner S, et al. Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19. J Nephrol. 2021 Aug;34(4):1007-018. DOI: 10.1007/s40620-021-01079-x Search in Google Scholar

47 Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014 Oct;25(10):2177-86. DOI: 10.1681/ASN.2013070758 Search in Google Scholar

48 Nica S, Nica RI, Toma M, Cimponeriu D, Cirstoiu FC, Cimpoesu DC.The interactions between risk factors for ischemic stroke. RJMM.2021 Jan; 124 (1):119-23. DOI: 10.55453/rjmm.2021.124.1.18 Search in Google Scholar

49 Tonkonogi A, Carlsson AC, Helmersson-Karlqvist J, Larsson A, Ärnlöv J. Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes. Ups J Med Sci. 2016 Aug; 21(3):174-78. DOI: 10.1080/03009734.2016.1192704 Search in Google Scholar

50 Brilland B, Boud’hors C, Wacrenier S, Blanchard S, Cayon J, Blanchet O, et al. Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis. Clin Kidney J. 2023 Apr 3;16(9):1521-33. DOI: 10.1093/ckj/sfad071 Search in Google Scholar

51 Tu Y, Wang H, Sun R, Ni Y, Ma L, Xv F, et al. Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Ren Fail. 2014 Nov;36(10):1559-63. DOI: 10.3109/0886022X.2014.949764 Search in Google Scholar

52 Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009 Nov;24(11):3265-68. DOI: 10.1093/ndt/gfp010 Search in Google Scholar

53 Abbas M, Alossaimi MA, Altamimi ASA, Alajaji M, Watson DG, Shah SI, et al. Determination of α1-acid glycoprotein (AGP) concentration by HPLC in patients following local infiltration analgesia for primary total hip arthroplasty and its relation to ropivacaine (total and unbound). Front Pharmacol. 2023 Jun 26;14:1145962. DOI: 10.3389/fphar.2023.1145962 Search in Google Scholar

54 Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol. 2015 JAN 7;10(1):147-55. DOI: 10.2215/CJN.12191213 Search in Google Scholar

55 Parikh CR, Liu C, Mor MK, Palevsky PM, Kaufman JS, Thiessen Philbrook H, et al. Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial. Am J Kidney Dis. 2020 Feb;75(2):187-94. DOI: 10.1053/j.ajkd.2019.06.011 Search in Google Scholar

56 Zhen XW, Song NP, Ma LH, Ma LN, Guo L, Yang XD. Calprotectin and Neutrophil Gelatinase-Associated Lipocalin As Biomarkers of Acute Kidney Injury in Acute Coronary Syndrome. Am J Med Sci. 2021 Jun; 361(6):736-43. DOI: 10.1016/j.amjms.2020.10.028 Search in Google Scholar

57 Yoon SY, Kim JS, Jeong KH, Kim SK. Acute Kidney Injury: Biomarker-Guided Diagnosis and Management. Medicina (Kaunas). 2022 Feb 23;58(3):340. DOI: 10.3390/medicina58030340 Search in Google Scholar

58 Canney M, Clark EG, Hiremath S. Biomarkers in acute kidney injury: On the cusp of a new era?. J Clin Invest. 2023 Jul 3;133(13):e171431. DOI: 10.1172/JCI171431 Search in Google Scholar

59 Tan D, Zhao L, Peng W, Wu FH, Zhang GB, Yang B, et al. Value of urine IL-8, NGAL and KIM-1 for the early diagnosis of acute kidney injury in patients with ureteroscopic lithotripsy related urosepsis. Chin J Traumatol. 2022 Jan;25(1):27-31. DOI: 10.1016/j. cjtee.2021.10.001 Search in Google Scholar

60 Liu Z, Yang D, Gao J, Xiang X, Hu X, Li S, et al. Discovery and validation of miR-452 as an effective biomarker for acute kidney injury in sepsis. Theranostics. 2020 Oct 25;10(26):11963-75. DOI: 10.7150/thno.50093 Search in Google Scholar

61 Rossiter A, La A, Koyner JL, Forni LG. New biomarkers in acute kidney injury. Crit Rev Clin Lab Sci. 2024 Jan; 61(1):23-44. DOI: 10.1080/10408363.2023.2242481 Search in Google Scholar

62 Vakili M, Fahimi D, Esfahani ST, Sharifzadeh M, Moghtaderi M. Comparative Analysis between Urinary Calprotectin and Serum Creatinine for Early Detection of Intrinsic Acute Kidney Injury. Indian J Nephrol. 2021 Jul-Aug;31(4):353-57. DOI: 10.4103/ijn. IJN_83_20 Search in Google Scholar

63 Chen JJ, Fan PC, Kou G, Chang SW, Chen YT, Lee CC, et al. Meta-Analysis: Urinary Calprotectin for Discrimination of Intrinsic and Prerenal Acute Kidney Injury. J Clin Med. 2019 Jan 10;8(1):74. DOI: 10.3390/jcm8010074 Search in Google Scholar

64 https://emedicine.medscape.com/article/1925619-overview#a3 Accessed June 2024 Search in Google Scholar